HTL0039732 Capsules

1 clinical trials involving this therapy/drug

This is not medical advice - consult your oncologist

Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.

RecruitingPhase I/IILung cancerCervical cancerColorectal cancerGastric cancerProstate cancerKidney cancerBladder cancerHead and neck cancerOther cancersMetastatic / advanced

HTL0039732 in Participants With Advanced Solid Tumours

NCT05944237ClinicalTrials.gov ↗

The purpose of this trial is to evaluate a new drug, HTL0039732, that will be administered on its own (as a monotherapy) and in combination with atezolizumab or with other approved anti-cancer therapies, in participants with advanced solid tumours.

Full details →

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.